Also, these limits, which can be completed with blockchain advancement, may be important for ensuring the advantages of data subjects as portrayed by the EU General Data Protection Regulation. Taking into account the normal size and affectability of clinical data, it is all around acknowledged that the name information of clinical data, not clinical data itself, will be taken care of in data blocks. Regardless, some huge information, similar to information on drug sensitivities, can be circulated in a public blockchain..
Posted Using LeoFinance Beta
As much as it's just easy to word that out, don't you think it just may be a little harder to implement?
Looking at the fact that the government give little or almost zero sensitive data out, do you expect this would quite function when the leads are technically against a transparent system?
That is why good governance is the foundation of every development....you are right dear...
Yes Yes, so technical approaches has to be in place. What's your thoughts on how that could be done?